Management of Diabetic Kidney Disease
The global prevalence of chronic kidney disease (CKD) from all causes is increasing with parallel increases in the number of people undergoing renal replacement therapy and increases in costs of care. The pathophysiology of diabetic kidney disease (DKD) is complex and heterogeneous. Clinical trials have shown benefits in renal outcomes with drugs acting on the renin-angiotensin-aldosterone system (RAAS) axis, as well as sodium-glucose cotransporter 2 (SGLT2) inhibitors, and GLP1RA. In this manuscript we review the management of diabetic kidney disease.
Authors
- U. Ayyagari
Institutions
- Apollo Hospitals (IN)
- Tamil Nadu Dr. M.G.R. Medical University (IN)
Publication Details
- Journal
- International journal of clinical metabolism and diabetes.
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1177/30502071261427510
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00